Entero Healthcare Solutions Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Entero Healthcare Solutions Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 93% of Healthcare companies in India.
- Tangible Net Worth Ratio: Of every ₹100 of net worth, ₹55 is tangible; the rest is goodwill and other intangibles, often from buying other companies. Less tangible than 87% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-0.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 93% of Healthcare companies in India.
Cash Locked Ratio
₹15For every ₹100 of sales, ₹15 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹19 tied up three years earlier.
Less money tied up than 68% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 83% of Healthcare companies in India.
Growth Efficiency Ratio
₹4Sales grew 99% in 3 years; of every extra ₹100 of sales, ₹4 became extra profit.
Lower than 80% of Healthcare companies in India.
Asset Productivity Ratio
+99% / +175%In 3 years sales changed by +99% while total assets changed by +175%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
0.2×Debt due within a year is covered 0.2 times by its yearly operating cash.
Lower than 82% of Healthcare companies in India.
Cash Cushion Ratio
−6%Debt, after subtracting cash, equals 6% of its market value (net debt).
Lower than 68% of Healthcare companies in India.
Tangible Assets Ratio
79%Of every ₹100 the company owns, ₹79 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 83% of Healthcare companies in India.
Tangible Net Worth Ratio
55%Of every ₹100 of net worth, ₹55 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 87% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Entero Healthcare Solutions Limited owes ₹0.51 for every ₹1 it owns. Net profit rose 21% in the year to Mar 2026.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
52.1Investors pay ₹52.1 for every ₹1 of Entero Healthcare Solutions Limited's yearly profit, higher than 72% of Healthcare companies in India.
P/B ratio
3.86The share price is 3.86 times Entero Healthcare Solutions Limited's book value per share, lower than 62% of Healthcare companies in India.
Market cap
₹6,524 CrThe total market value of all of Entero Healthcare Solutions Limited's shares at today's price (share price × number of shares), larger than 55% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹1,689 CrWhat Entero Healthcare Solutions Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹387.98Net worth divided by the number of shares. The share price of ₹1,499 is 3.9 times this, which is the P/B above.
Return on equity (ROE)
7.4%Entero Healthcare Solutions Limited earned 7.4% on its shareholders' money over the last year, lower than 76% of Healthcare companies in India.
Owes vs Owns
0.51×Entero Healthcare Solutions Limited owes ₹0.51 for every ₹1 it owns (moderate), higher than 87% of Healthcare companies in India.
Dividend yield
NoneEntero Healthcare Solutions Limited does not currently pay a dividend.
Revenue growth
+29%Revenue rose 29% in the year to Mar 2026, and grew 26% a year on average over 3 years.
Profit growth
+21%Net profit rose 21% in the year to Mar 2026.
Profit margin
1.8%Entero Healthcare Solutions Limited keeps ₹2 of every ₹100 of revenue as net profit.
Cash quality
0.8×Cash from Entero Healthcare Solutions Limited's business was 0.8× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.
Interest cover
4.6×Entero Healthcare Solutions Limited's operating profit covered its interest costs 4.6 times in the year to Mar 2026.
Cash vs debt
Net debtEntero Healthcare Solutions Limited had ₹381 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Entero Healthcare Solutions Limited's P/E ratio?
Investors pay ₹52.1 for every ₹1 of Entero Healthcare Solutions Limited's yearly profit, higher than 72% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Entero Healthcare Solutions Limited: ₹6,524 Cr ÷ ₹1,689 Cr (31 Mar 2026) = 3.9.
What is Entero Healthcare Solutions Limited's return on equity?
Entero Healthcare Solutions Limited earned 7.4% on its shareholders' money over the last year, lower than 76% of Healthcare companies in India.
How much does Entero Healthcare Solutions Limited owe compared with what it owns?
Entero Healthcare Solutions Limited owes ₹0.51 for every ₹1 it owns (moderate), higher than 87% of Healthcare companies in India.
Does Entero Healthcare Solutions Limited pay a dividend?
No. Entero Healthcare Solutions Limited does not currently pay a dividend.
Is Entero Healthcare Solutions Limited's revenue growing?
Revenue rose 29% in the year to Mar 2026, and grew 26% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.